instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Product A adverse event and previous Product B therapy report
Dear Drug Safety Department,
I am the Consultant Rheumatologist at a gastroenterology clinic partnership and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Pharmacovigilance report Product A with Amoxicillin continued without change
To Whom It May Concern,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 67 year old female patient initiated on P... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my father Maria Wilson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Formal adverse event notification Product A with Amoxicillin continued without change
Dear Global Safety Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 60 year old male patient on Pro... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse event notification for Product A with Product B no longer taken
Dear Post-Marketing Surveillance Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 34 year old female patient on P... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A reaction and Atorvastatin stable during Product A reaction formal notification
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 41 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Urgent adverse event Product A and Product A and Atorvastatin both implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Nephrologist at a chain of retail pharmacies and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adv... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Serious adverse event report Product A and concurrent Product B use
Dear Post-Marketing Surveillance Unit,
I am the Clinical Pharmacy Director at a regional hospital trust and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected adverse reaction with Lisinopril concomitant medication only
Dear Medical Affairs and Drug Safety,
I am the Clinical Pharmacist at a multi-site primary care network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am the Consultant Hepatologist at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event wher... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Pharmacovigilance report Product A with Product B not currently administered
Good morning,
I am the Director of Clinical Services at a pathology and diagnostics consortium and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A reaction and Product B completed treatment historically formal notification
Dear Pharmacovigilance and Risk Management Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse event report Product A plus Product B taken alongside
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my father Timothy Lopez to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 29 year... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Suspected adverse event with Product A and concurrent Product B use
Good morning,
I am the Senior Nurse Practitioner at a private cardiology practice group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 42... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Safety report Product A and suspect Product B also implicated
Dear Sir or Madam,
I am writing as the caregiver for my wife Virginia Santos to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician suspects both medi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A adverse reaction with historical Product B use
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my wife Susan Ruiz to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 50 year old female... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Adverse reaction report involving Product A and Amoxicillin not implicated in adverse event
Dear Post-Marketing Surveillance Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 59 year old... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Formal adverse event notification Product A with Product B taken alongside
Dear Patient Safety Team,
I am the Chief of Medicine at a childrens hospital outpatient department and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Chief of Medicine at a pharmaceutical benefit manager and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A adverse reaction with ongoing Product B treatment
Hi,
I am the Chief of Medicine at a group of private outpatient clinics and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 68 year old male patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A adverse event and both Product A and Levothyroxine identified as suspect report
Dear Corporate Drug Safety Department,
I am the Consultant Pulmonologist at a managed care organisation and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected adverse reaction with Omeprazole unchanged during event onset
To Whom It May Concern,
I am writing as the caregiver for my husband Edward Andrews to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Patient Safety Team,
I am writing as the caregiver for my wife Katherine Price to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Urgent adverse event Product A and Product B completed treatment historically
Dear Regional Pharmacovigilance Lead,
I am the Chief of Medicine at a corporate occupational health provider and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A adverse reaction with previous Product B therapy
Dear Drug Safety Department,
I am writing as the caregiver for my father Jacob Martin to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 62 year old male pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A reaction and Amoxicillin concomitant medication only formal notification
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my wife Henry Cook to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse event notification for Product A with Omeprazole stable during Product A reaction
Dear Corporate Drug Safety Department,
I am the Chief of Medicine at a residential care home network managing over 400 elderly residents across 5 facilities and I am formally notifying you of an adverse event report requi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am writing as the caregiver for my father Adam Hicks to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Safety report Product A and suspected combined effect Product A and Amlodipine
Dear Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician susp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse reaction report involving Product A and suspected Amlodipine co-reaction
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Dear Post-Marketing Surveillance Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected reaction with Amoxicillin excluded as causative agent – formal report
Dear Global Safety Unit,
I am the Consultant Gastroenterologist at a community health partnership covering 12 clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to repo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Suspected adverse event with Product A and Amlodipine concomitant medication only
Dear Regional Pharmacovigilance Lead,
I am the Clinical Pharmacist at a rehabilitation and long-term care facility and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Urgent adverse event Product A and Amlodipine concomitant medication only
Hi,
I am writing as the caregiver for my mother Kenneth Roberts to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 64 year old male patient on ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Formal adverse event notification Product A with Product B unchanged during reaction
Good morning,
I am the Consultant Haematologist at a multi-site primary care network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Pharmacovigilance report Product A with Product B not currently administered
Dear Pharmacovigilance Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 58 year old mal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
Dear Sir or Madam,
I am the Pharmacy Operations Manager at a community health partnership covering 12 clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to repor... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A reaction report with Omeprazole continued without change
Hi,
I am the Consultant Dermatologist at a private cardiology practice group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 48 year old femal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Safety report Product A and past Product B exposure
Dear Corporate Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 73 year old male patient start... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse reaction with Product B not suspected
Dear Patient Safety Team,
I am the Senior Consultant at a rural district hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 45 year old female pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Formal adverse event notification Product A with Ibuprofen maintained as background medication
Dear Corporate Drug Safety Department,
I am the Consultant Dermatologist at a group of private outpatient clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to rep... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A adverse event and both Product A and Amlodipine identified as suspect report
Dear Post-Marketing Surveillance Unit,
I am the Senior Nurse Practitioner at a private cardiology practice group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A reaction and Lisinopril excluded as causative agent formal notification
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 59 year old mal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Pharmacovigilance report Product A with suspected Metformin co-reaction
Hi,
I am writing as the caregiver for my mother Linda Gordon to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician suspects both medication... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Formal adverse event notification Product A with historical Product B use
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 53 year old female patient sta... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Pharmacovigilance Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A suspected reaction with Product B not currently administered – formal report
Dear Adverse Events Reporting Centre,
I am the Clinical Pharmacy Director at a pain management clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
To Whom It May Concern,
I am writing as the caregiver for my mother Anthony Delgado to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Adverse reaction report involving Product A and Product B historical medication only
Dear Pharmacovigilance Team,
I am the Chief of Medicine at a private oncology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A reaction report with previous Product B therapy
Dear Drug Safety Department,
I am the Senior Nurse Practitioner at a rheumatology clinic group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 29 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse event report Product A plus Ibuprofen also suspected by physician
Dear Medical Affairs and Drug Safety,
I am the Director of Clinical Services at a hepatology referral centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse event notification for Product A with Omeprazole excluded as causative agent
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old female... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A adverse reaction with Product B implicated only as concomitant
Dear Pharmacovigilance Team,
I am the Clinical Pharmacist at an immunology and allergy clinic and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event.... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Pharmacovigilance report Product A with Levothyroxine stable during Product A reaction
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my father Maria Elliott to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event report Product A plus both Product A and Lisinopril identified as suspect
Dear Medical Affairs and Drug Safety,
I am the Consultant Neurologist at a regional hospital trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Suspected adverse event with Product A and past Product B exposure
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Dermatologist at a geriatric medicine consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected adverse reaction with Product B as background therapy
Dear Corporate Drug Safety Department,
I am the Attending Physician at a surgical day case unit group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am the Head of Pharmacy Services at a childrens hospital outpatient department and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wis... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A adverse reaction with suspected combined effect Product A and Amlodipine
Dear Pharmacovigilance Team,
I am the Clinical Nurse Specialist at a private oncology clinic group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and Product B unchanged during reaction
Dear Clinical Safety and Regulatory Affairs,
I am the Director of Clinical Services at a rheumatology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Suspected adverse event with Product A and Product A and Amoxicillin both implicated
Dear Sir or Madam,
I am the Consultant Nephrologist at a rheumatology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the tre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse reaction report involving Product A and ongoing Product B treatment
Hi,
I am the Senior Nurse Practitioner at a large academic medical centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 48 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Ward Nurse Manager at a cancer centre network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A reaction report with suspected Amoxicillin co-reaction
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my mother Pamela Roberts to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating phys... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my sister Diane Cole to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the tre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A adverse event and Levothyroxine stable during Product A reaction report
Good morning,
I am the Senior Nurse Practitioner at a faith-based hospital system and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event report Product A plus ongoing Atorvastatin use alongside Product A
Good morning,
I am the Pharmacy Operations Manager at a cancer centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A adverse event and Amlodipine stable during Product A reaction report
Dear Sir or Madam,
I am writing as the caregiver for my father Matthew Armstrong to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 53 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A adverse reaction with Levothyroxine unchanged during event onset
Dear Pharmacovigilance Team,
I am the Clinical Pharmacy Director at a university hospital department and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Clinical Pharmacist at a rehabilitation and long-term care facility and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A adverse event and Product B past use excluded report
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 45 year old female patient initiated on ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Suspected adverse event with Product A and Product A and Methotrexate both implicated
Good morning,
I am the Consultant Cardiologist at a clinical research site network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the tr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Pharmacovigilance Team,
I am the Consultant Neurologist at a dialysis centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the trea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Urgent adverse event Product A and past Product B exposure
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 29 year old femal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Formal adverse event notification Product A with Levothyroxine also suspected by physician
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as contribut... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Suspected adverse event with Product A and physician suspects both Product A and Ibuprofen
To Whom It May Concern,
I am the Senior Consultant at a clinical research site network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Pharmacovigilance report Product A with Product A and Lisinopril both implicated
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my wife Kathleen Hudson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Patient Safety Team,
I am the Clinical Pharmacy Director at a paediatric outpatient service and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Formal adverse event notification Product A with Product B stopped before symptoms began
Dear Patient Safety Team,
I am the Consultant Neurologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Adverse event notification for Product A with Product B completed course before reaction
Dear Regional Pharmacovigilance Lead,
I am the Consultant Pulmonologist at a large endocrinology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A suspected reaction with dual suspect Product A and Levothyroxine – formal report
Dear Pharmacovigilance Team,
I am the Consultant Gastroenterologist at a corporate occupational health provider and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A suspected reaction with Product A and Atorvastatin jointly suspected – formal report
Dear Pharmacovigilance and Risk Management Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Safety report Product A and Product B taken alongside
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 48 year old female patient on Product A for 14 weeks ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Pharmacovigilance and Risk Management Team,
I am the Pharmacy Operations Manager at a cancer centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A suspected adverse reaction with Product B historical exposure documented
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my mother Rebecca Thomas to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A suspected reaction with previous Product B therapy – formal report
Dear Pharmacovigilance and Risk Management Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Pharmacovigilance report Product A with Atorvastatin maintained as background medication
Dear Clinical Safety and Regulatory Affairs,
I am the Head of Pharmacy Services at a cancer centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wis... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A reaction report with Product B no longer taken
Dear Corporate Drug Safety Department,
I am the Consultant Hepatologist at a university hospital department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Medical Director at a gastroenterology clinic partnership and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
To Whom It May Concern,
I am the Consultant Haematologist at a corporate occupational health provider and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Pharmacovigilance report Product A with Product B as background therapy
Dear Pharmacovigilance and Risk Management Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Patient Safety Team,
I am the Head of Pharmacy Services at a childrens hospital outpatient department and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A suspected reaction with Product B stopped before symptoms began – formal report
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my husband Samuel Hall to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Safety report Product A and both Product A and Methotrexate identified as suspect
Good morning,
I am the Ward Nurse Manager at a clinical research site network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event where the treating... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Sir or Madam,
I am the Medical Director at a private oncology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event where the trea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A reaction and physician suspects both Product A and Metformin formal notification
Dear Drug Safety Department,
I am the Consultant Hepatologist at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Suspected adverse event with Product A and Metformin stable during Product A reaction
Good morning,
I am the Consultant Rheumatologist at a geriatric medicine consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.